Maxime Ranger

Maxime Ranger, PhD, MBA

Chief Executive Officer, Chairman of the Board

BIOGRAPHY

Dr. Ranger is a serial entrepreneur who created several biotech startups in the Greater Montreal area including SemaThera (exclusive license with Roche, 2021), Inversago Pharma and Giiant Pharma (exclusive license with Palisade Bio, 2023). Inversago was acquired for US $1.075B in 2023, after raising about US $100M. Maxime has 25 years of experience in drug development and successfully completed multiple fundraising campaigns, especially in two broad areas: gastroenterology and ophthalmology. He holds a PhD in chemistry from Université Laval and completed a postdoctoral fellowship at Stanford University. He also completed a joint executive MBA at UQAM and Université Paris-Dauphine.

back to team